MMP9 and melanoma: MMP-2 and MMP-9 are linked to VM and poor prognosis in cancers of the breast, ovaries, prostate, liver, stomach and kidneys, along with GISTs, mesothelial sarcomas, rhabdomyosarcomas and melanomas [6, 9–10, 13–14, 16].